| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/12/2009 | US7531337 Method of controlling acetylation of metabolic enzymes |
| 05/12/2009 | US7531335 Modified cytochrome p450 monooxygenases |
| 05/12/2009 | US7531333 Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
| 05/12/2009 | US7531328 Methods and devices for multiplexing amplification reactions |
| 05/12/2009 | US7531324 Interferon-alpha polypeptides and conjugates |
| 05/12/2009 | US7531320 Modulation of β-catenin/TCF-activated transcription |
| 05/12/2009 | US7531318 Screening of agents for activity against ischemic myocardial insults |
| 05/12/2009 | US7531317 Fluorescence polarization assay to detect protease cleavage |
| 05/12/2009 | US7531316 complexing a radiolabeled platelet-activating factor (PAF) with a sequestering molecule comprising exogenous albumin, to form a PAF-sequester molecule complex, then determining lipoprotein-associated phospholipase A2 (Lp-PLA2) enzyme activity in samples, by measuring the cleavage of the complex |
| 05/12/2009 | US7531312 Simplified biological evaluation method of natural and artificial chemicals by using DNA injury index and apparatus therefor |
| 05/12/2009 | US7531311 determining the amount of a polynucleotide sequence or a fragment of at least 20 consecutive nucleotides in a test sample and comparing the amount with that from a control, wherein an increase indicates a gastrointestinal disorder |
| 05/12/2009 | US7531310 Methods of diagnosing Crohn's disease by measuring expression level of RNA encoding human G-protein coupled receptor, HGPRBMY11 |
| 05/12/2009 | US7531309 contacting a sample of streptococcus with genetic primers, such that amplicons comprising portions capsular genes of the streptococcus is produced, then contacting the amplicon with restriction enzyme, to generate restriction fragments and determining the serotype, based on the size of the fragments |
| 05/12/2009 | US7531308 Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography |
| 05/12/2009 | US7531307 Use of representations of DNA for genetic analysis |
| 05/12/2009 | US7531306 Nucleic acid hybridization methods |
| 05/12/2009 | US7531305 Amplifying and labeling gene; hybridizing to solid support and detecting caputred fragments; kits |
| 05/12/2009 | US7531304 Method for screening FGFR-4 agonists |
| 05/12/2009 | US7531303 Interrogating multi-featured arrays |
| 05/12/2009 | US7531302 Nucleic acid detection method by triple helix formation |
| 05/12/2009 | US7531301 Systems and methods for identifying organ transplant risk |
| 05/12/2009 | US7531300 contacting drugs with protein kinases, then detecting the binding activity, selecting the drugs that binds to the kinase, contacting the selected drugs with breast cancer cells and further selecting the drugs that suppresses cell growth of breast cancer cells; screening for antiproliferative agents |
| 05/12/2009 | US7531163 Enrichment methods for the detection of pathogens and other microbes |
| 05/12/2009 | US7530197 Automated system and method for harvesting and multi-stage screening of plant embryos |
| 05/12/2009 | CA2482307C Quantitative measure of gene expression |
| 05/12/2009 | CA2396052C Increased lysine production by gene amplification |
| 05/12/2009 | CA2286279C Diagnosis of neuro-degenerative disorders |
| 05/12/2009 | CA2284559C Agglutrimetric assays in blood |
| 05/12/2009 | CA2262923C Article and method for detection of enterotoxigenic staphylococci |
| 05/12/2009 | CA2244195C Pin m iii gene in white pine |
| 05/12/2009 | CA2199490C Dye couple for spectrophotometric determination of analytes |
| 05/12/2009 | CA2194457C Microbiological test method and reagents |
| 05/12/2009 | CA2192744C Stable coupling dye for photometric determination of analytes |
| 05/12/2009 | CA2141430C Nucleic acid sequence amplification |
| 05/07/2009 | WO2009059327A2 Compositions and methods comprising biomarkers of sperm quality, semen quality and fertility |
| 05/07/2009 | WO2009059322A1 Methods for predicting the development and resolution of acute respiratory distress syndrome |
| 05/07/2009 | WO2009059321A2 Rca locus analysis to assess susceptibility to amd and mpgnii |
| 05/07/2009 | WO2009059319A1 Assessing susceptibility to vascular disorders |
| 05/07/2009 | WO2009059318A2 Genes and polymorphisms associated with amd |
| 05/07/2009 | WO2009059317A2 Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715 |
| 05/07/2009 | WO2009059259A2 Detection of worsening renal disease in subjects with systemic lupus erythematosus |
| 05/07/2009 | WO2009059142A1 Panel for the detection and differentiation of renal cortical neoplasms |
| 05/07/2009 | WO2009059049A1 Methods and kits for multiplex amplification of short tandem repeat loci |
| 05/07/2009 | WO2009059026A1 Process for monitoring colorectal cancer |
| 05/07/2009 | WO2009059021A2 Hcv genotyping and phenotyping |
| 05/07/2009 | WO2009059016A1 Process for predicting the prognosis of squamous cell lung cancer |
| 05/07/2009 | WO2009058908A2 Methods for prognosing the ability of a zearalenone analog compound to treat cancer |
| 05/07/2009 | WO2009058881A1 Osteoarthritis gene therapy |
| 05/07/2009 | WO2009058867A2 Affinity measurements using frameless multiplexed microarrays |
| 05/07/2009 | WO2009058852A2 Minor groove binder-energy transfer oligonucleotides and methods for their use |
| 05/07/2009 | WO2009058446A1 Recombinant factor viii having increased stability |
| 05/07/2009 | WO2009058380A2 Biomarkers predictive of acute coronary syndromes |
| 05/07/2009 | WO2009058364A1 Cell-free methods for detecting protein-ligand interctions |
| 05/07/2009 | WO2009058363A1 Antibody to rage and uses for in vivo imaging or for targeting therapy |
| 05/07/2009 | WO2009058335A1 Major qtls conferring resistance of corn to fijivirus |
| 05/07/2009 | WO2009058214A1 High capacity nanoparticulate immobilization surface |
| 05/07/2009 | WO2009058016A1 Method of pooling samples for performing a bi0l0gical assay |
| 05/07/2009 | WO2009058007A2 Methods, reagents and kits for luciferase assay |
| 05/07/2009 | WO2009057993A1 NEW DETECTION METHOD FOR CERVICAL HPVs |
| 05/07/2009 | WO2009057931A2 Dried composition for hot-start pcr with long-term stability |
| 05/07/2009 | WO2009057849A1 Colon cancer diagnostic markers using up-regulated genes |
| 05/07/2009 | WO2009057829A2 Nucleic acid primer set for detection of drug-resistant strain of hepatitis b virus, assay kit, and method of detecting drug-resistant strain of hepatitis b virus |
| 05/07/2009 | WO2009057757A1 Base sequence determination program, base sequence determination system and base sequence determination method |
| 05/07/2009 | WO2009057755A1 Sugar chain array substrate and method for detection of sugar chain-binding molecule using the same |
| 05/07/2009 | WO2009057702A1 Polymer for detection of target substance, and method for detection of target substance |
| 05/07/2009 | WO2009057695A1 Method for detection of adenoma or cancer by genetic analysis |
| 05/07/2009 | WO2009057640A1 Method for determination of inflammatory disease by using single nucleotide polymorphism in brca1-related protein (brap) gene |
| 05/07/2009 | WO2009057525A1 Cell analysis apparatus and cell analysis method |
| 05/07/2009 | WO2009057330A1 Method and kit for detection/quantification of target rna |
| 05/07/2009 | WO2009057294A1 Gene associated with liver cancer, and method for determination of the risk of acquiring liver cancer |
| 05/07/2009 | WO2009057119A2 Glycemic control for reduction of cardiovascular disease risk in diabetic patients expressing haptoglobin 2-2 |
| 05/07/2009 | WO2009057113A2 Diagnosis and prognosis of specific cancers by means of differential detection of micro-rnas/mirnas |
| 05/07/2009 | WO2009057061A1 Transgenic plants and modulators for improved stress tolerance |
| 05/07/2009 | WO2009057014A2 Automatic detection of infectious diseases |
| 05/07/2009 | WO2009056966A1 Near full-genome assay of hcv drug resistance |
| 05/07/2009 | WO2009056862A2 Prostate cancer susceptibility screening |
| 05/07/2009 | WO2009056831A1 Polymerase-based single-molecule sequencing |
| 05/07/2009 | WO2009056762A2 Biochemical test for confirming the presence of l. monocytogenes |
| 05/07/2009 | WO2009056366A1 Gene-based algorithmic cancer prognosis and clinical outcome of a patient |
| 05/07/2009 | WO2009056343A1 Method for determining frameshift mutations in coding nucleic acids |
| 05/07/2009 | WO2009056339A1 Means and methods for the detection and isolation of fetal and embryonic cells and nucleic acid from maternal body fluid |
| 05/07/2009 | WO2009056299A1 Electrical patterns for biosensor and method of making |
| 05/07/2009 | WO2009056065A1 Bioassay system including optical detection apparatuses, and method for detecting biomolecules |
| 05/07/2009 | WO2009055979A1 Micrornas in serum/blood plasma and their uses |
| 05/07/2009 | WO2009055926A1 Method of determining risk for cancer |
| 05/07/2009 | WO2009055907A1 Apoptin induces inhibition of bcr-abl kinase in cml cells |
| 05/07/2009 | WO2009039640A9 A system, apparatus and method for applying mechanical force to a material |
| 05/07/2009 | WO2009039170A3 Integrated protein chip assay |
| 05/07/2009 | WO2009038742A3 Method for estimating risk of acute kidney injury |
| 05/07/2009 | WO2009037266A3 Method for detecting or quantifying a truncating mutation |
| 05/07/2009 | WO2009036299A3 Compositions and methods for the identification of inhibitors of retroviral infection |
| 05/07/2009 | WO2009032781A3 Methods and compositions for universal size-specific polymerase chain reaction |
| 05/07/2009 | WO2009032779A3 Methods and compositions for the size-specific seperation of nucleic acid from a sample |
| 05/07/2009 | WO2009030770A3 Methods and tools for prognosis of cancer in er- patients |
| 05/07/2009 | WO2009029587A3 Compositions and methods for diagnosing and treating macular degeneration |
| 05/07/2009 | WO2009025852A3 Methods of using mirna for detection of in vivo cell death |
| 05/07/2009 | WO2009020645A3 Matriptase protein and uses thereof |
| 05/07/2009 | WO2009018335A9 Targeting brain cells via ophtalmic delivery |
| 05/07/2009 | WO2009013614A3 Marker gene |
| 05/07/2009 | WO2009007934A3 Cd44 splice variants in neurodegenerative diseases |